| Authors: |
Pawlyn C; The Institute of Cancer Research, London, United Kingdom., Kaiser MF; The Institute of Cancer Research, London, United Kingdom., Heuck C; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Melchor L; The Institute of Cancer Research, London, United Kingdom., Wardell CP; The Institute of Cancer Research, London, United Kingdom., Murison A; The Institute of Cancer Research, London, United Kingdom., Chavan SS; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Johnson DC; The Institute of Cancer Research, London, United Kingdom., Begum DB; The Institute of Cancer Research, London, United Kingdom., Dahir NM; The Institute of Cancer Research, London, United Kingdom., Proszek PZ; The Institute of Cancer Research, London, United Kingdom., Cairns DA; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom., Boyle EM; The Institute of Cancer Research, London, United Kingdom., Jones JR; The Institute of Cancer Research, London, United Kingdom., Cook G; University of Leeds, Leeds, United Kingdom., Drayson MT; Clinical Immunology, School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom., Owen RG; St James's University Hospital, Leeds, United Kingdom., Gregory WM; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom., Jackson GH; Department of Haematology, Newcastle University, Newcastle, United Kingdom., Barlogie B; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Davies FE; The Institute of Cancer Research, London, United Kingdom.; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Walker BA; The Institute of Cancer Research, London, United Kingdom.; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Morgan GJ; The Institute of Cancer Research, London, United Kingdom. GJMorgan@uams.edu.; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas. |
